Story perspectives

Psilocybin Therapy Offers Lasting Relief for Depression

9/17/2025

44 4

Summary

Story summary

A study shows that patients with clinical depression treated with psilocybin-assisted therapy remain symptom-free five years later.
Two-thirds of participants achieved complete remission, indicating lasting wellbeing improvements.
Led by Professor Alan Davis from Ohio State University, the study builds on a 2021 trial.
Participants described the therapy as a profound experience, akin to major life events.
Findings were published in the Journal of Psychedelic Studies on September 4, 2025.

1 of 1

Story summary

A study shows that patients with clinical depression treated with psilocybin-assisted therapy remain symptom-free five years later.
Two-thirds of participants achieved complete remission, indicating lasting wellbeing improvements.
Led by Professor Alan Davis from Ohio State University, the study builds on a 2021 trial.
Participants described the therapy as a profound experience, akin to major life events.
Findings were published in the Journal of Psychedelic Studies on September 4, 2025.